Trial Profile
Clinical Trials Insight: 700033629
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 16 May 2008
Price :
$35
*
At a glance
- Drugs VEL 0230 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Velcura Therapeutics
- 16 May 2008 New trial record.